CRISPR Therapeutics AG - Company Profile

Powered by

All the sales intelligence you need on CRISPR Therapeutics AG in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how CRISPR Therapeutics AG fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with CRISPR Therapeutics AG.

Back to companies

CRISPR Therapeutics AG: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

The following section provides information on CRISPR Therapeutics AG’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into CRISPR Therapeutics AG's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Samarth Kulkarni

Chief Executive Officer; Chairman; Director Executive Board Since: 2023

Mr. Samarth Kulkarni has been the Chairman of the company since 2023. He also serves as the Chief Executive Officer and Director of the company since 2017. Prior to this, he served as the Chief Business Officer at CRISPR from 2015 to 2017. Mr. Kulkarni also served as a Partner at McKinsey and Company. While at McKinsey, he co-led the biotech practice and served a number of biotechnology companies on topics ranging from strategy to operations.

Read Hide full bio of Samarth Kulkarni

Raju Prasad, Ph.D.

Chief Financial Officer Senior Management Since: 2023

Mr. Raju Prasad, Ph.D has been the Chief Financial Officer of the company since March 2023. Prior to this, he served as a partner at William Blair & Company From March 2014 to 2023. Previously he served as University of North Carolina at Chapel Hill’s Gillings School of Global Public Health and U.S. Environmental Protection Agency.

Read Hide full bio of Raju Prasad, Ph.D.

Naimish Patel, M.D.

Chief Medical Officer Senior Management Since: 2024

Mr. Naimish Patel, M.D. has been the Chief Medical Officer of the company since May 2024. Prior to this he served as Head of Immunology and Inflammation at Sanofi.

Read Hide full bio of Naimish Patel, M.D.

Megan Wherry Menner

Head - Human Resources Senior Management

James R. Kasinger

Secretary; General Counsel Senior Management Since: 2017
Gain a 360-degree view of CRISPR Therapeutics AG and make more informed decisions for your business Gain a 360-degree view of CRISPR Therapeutics AG and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer